Pictet Asset Management (Switzerland)’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-391	Closed	-$8K	–	2022
2022 Q3	$8K	Hold	391	–	–	﹤0.01%	1564
2022 Q2	$9K	Hold	391	–	–	﹤0.01%	1573
2022 Q1	$19K	Hold	391	–	–	﹤0.01%	1676
2021 Q4	$27K	Hold	391	–	–	﹤0.01%	1713
2021 Q3	$36K	Buy	+391	New	+$37.1K	﹤0.01%	1736

Other funds holding VBIV

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s VBIV Position: Q4 2022 in Review

Pictet Asset Management (Switzerland) sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q4 2022, closing a stake of 391 shares — an estimated $8K sold.

Pictet Asset Management (Switzerland) first reported a position in VBIV in Q3 2021 and held it in 5 quarters. The position peaked at $36K in Q3 2021. 112 funds tracked by Wall St. Rank hold VBIV as of Q4 2022.

Pictet Asset Management (Switzerland) reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q4 2022 after selling out during the quarter.
Pictet Asset Management (Switzerland) sold 391 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q4 2022, an estimated $8K.
Pictet Asset Management (Switzerland) first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q3 2021 and held it in 5 quarters.
Pictet Asset Management (Switzerland)'s VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $36K in Q3 2021.
112 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q4 2022.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q4 2022, filed 13 Feb 2023.